Businessweek

Bal Pharma Limited engages in the manufacture and marketing of pharmaceutical formulations and active pharmaceutical ingredients in India. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It also provides a range of active pharmaceutical ingredients in various therapeutic usages, including acne treatment, diuretic, anti-histamine, anti-inflammatory, anti-diabetic, sedative/hypnotic, anti-allergy, neuropathic pain, urinary incontinence, anti-convulsant, and insomnia. The company’s ayurvedic products comprise ANARSHA for regularize bowl movement; Ashwamed for sexual and general debility; AYURFINE and AYURFINE forte anti arthritics for osteoarthritis, rheumatoid arthritis, and spondylitis; Ayursulin for managing diabetes; IMMUWIN, an immune building supplement; and Lipived for reducing cholesterol. Its ayurvedic products also consists of MENOLEAP Capsules and Syrup for menstrual disorders; PROLIFE, which provides life to ailing liver; BALPRO SYRUP for stable and synchronized liver functions; PROSTOWIN for benign prostatic hyperplasia; STONEX for expulsion of kidney stones; Sujirna for digestion; Suswas, an antallergic/antiasthamatic product; and Balvac, a mild laxative. The company also exports its products to Europe, Latin America, Africa, the Middle East, and Asian markets. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.